JP2016508121A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016508121A5 JP2016508121A5 JP2015545885A JP2015545885A JP2016508121A5 JP 2016508121 A5 JP2016508121 A5 JP 2016508121A5 JP 2015545885 A JP2015545885 A JP 2015545885A JP 2015545885 A JP2015545885 A JP 2015545885A JP 2016508121 A5 JP2016508121 A5 JP 2016508121A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- immunosuppressive
- immunosuppressive tat
- tat derivative
- appendix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261734135P | 2012-12-06 | 2012-12-06 | |
| US61/734,135 | 2012-12-06 | ||
| US201361881266P | 2013-09-23 | 2013-09-23 | |
| US61/881,266 | 2013-09-23 | ||
| PCT/US2013/073658 WO2014089480A1 (en) | 2012-12-06 | 2013-12-06 | Treatment of inflammation, autoimmune, and neurodegenerative disorders with immunosuppressive tat derivative polypeptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019071040A Division JP2019163259A (ja) | 2012-12-06 | 2019-04-03 | 免疫抑制性Ｔａｔ誘導体ポリペプチドを用いた炎症、自己免疫及び神経変性疾患の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016508121A JP2016508121A (ja) | 2016-03-17 |
| JP2016508121A5 true JP2016508121A5 (https=) | 2017-01-26 |
| JP6607784B2 JP6607784B2 (ja) | 2019-11-20 |
Family
ID=50884040
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015545885A Expired - Fee Related JP6607784B2 (ja) | 2012-12-06 | 2013-12-06 | 免疫抑制性Ｔａｔ誘導体ポリペプチドを用いた炎症、自己免疫及び神経変性疾患の治療 |
| JP2019071040A Pending JP2019163259A (ja) | 2012-12-06 | 2019-04-03 | 免疫抑制性Ｔａｔ誘導体ポリペプチドを用いた炎症、自己免疫及び神経変性疾患の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019071040A Pending JP2019163259A (ja) | 2012-12-06 | 2019-04-03 | 免疫抑制性Ｔａｔ誘導体ポリペプチドを用いた炎症、自己免疫及び神経変性疾患の治療 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US9878001B2 (https=) |
| EP (1) | EP2928910B1 (https=) |
| JP (2) | JP6607784B2 (https=) |
| CN (1) | CN104981479B (https=) |
| AU (1) | AU2013355039B2 (https=) |
| CA (1) | CA2894166A1 (https=) |
| DK (1) | DK2928910T3 (https=) |
| ES (1) | ES2748423T3 (https=) |
| IL (1) | IL239271B (https=) |
| NZ (1) | NZ708836A (https=) |
| RU (1) | RU2653754C2 (https=) |
| WO (1) | WO2014089480A1 (https=) |
| ZA (1) | ZA201504100B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105705164A (zh) * | 2013-10-04 | 2016-06-22 | 品诺制药公司 | 用于癌症治疗的免疫刺激性hiv tat衍生多肽 |
| WO2017079161A2 (en) | 2015-11-02 | 2017-05-11 | Neuraltus Pharmaceuticals, Inc. | Treatment of neurodegenerative disease with sodium chlorite |
| MX2019006848A (es) * | 2016-12-13 | 2019-10-07 | Defensin Therapeutics Aps | Metodos para tratar condiciones inflamatorias de los pulmones. |
| EP3964225A1 (en) * | 2020-09-04 | 2022-03-09 | Dompe' Farmaceutici S.P.A. | Peptides endowed with angiogenic activity |
| CA3192758A1 (en) * | 2020-09-04 | 2022-03-10 | Dompe' Farmaceutici Spa | Peptides endowed with angiogenic activity |
| US20230364112A1 (en) * | 2020-09-29 | 2023-11-16 | Alps Biotech Co., Ltd. | Use of Antcin H and Its Derivatives for Treating Central Nervous System Diseases |
| EP4412624A4 (en) | 2021-10-04 | 2025-08-20 | Neuvivo Inc | TREATMENT METHODS FOR ALS PATIENTS |
| WO2023062451A1 (en) * | 2022-08-28 | 2023-04-20 | Farhadi Andar Abi Ali | Pegylated tat-efsevin-ta as an antiarrhythmic agent with favorable effect on heart failure caused by arrhythmia |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5891994A (en) | 1997-07-11 | 1999-04-06 | Thymon L.L.C. | Methods and compositions for impairing multiplication of HIV-1 |
| FR2792206B1 (fr) | 1999-04-13 | 2006-08-04 | Centre Nat Rech Scient | Vaccin anti-vih-1 comprenant tout ou partie de la proteine tat de vih-1 |
| US20050226890A1 (en) * | 1999-08-12 | 2005-10-13 | Cohen David I | Tat-based vaccine compositions and methods of making and using same |
| US8323928B2 (en) | 1999-08-12 | 2012-12-04 | Pin Pharma, Inc. | Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) transactivator of transcription protein for the treatment and prevention of HIV disease |
| ATE465754T1 (de) | 1999-08-12 | 2010-05-15 | Inist Inc | Nicht-immunsuppresives hiv tat-protein |
| US20070248618A1 (en) | 2004-03-16 | 2007-10-25 | Cohen David I | Tat-Based vaccine Compositions and Methods of Making and Using Same |
| US20080044435A1 (en) | 2004-03-16 | 2008-02-21 | Cohen David I | Tat-Based Tolerogen Compositions and Methods of Making and Using Same |
| NO314587B1 (no) * | 2000-09-04 | 2003-04-14 | Bionor Immuno As | HIV regulatoriske- og hjelpepeptider, antigener, vaksinepreparater, immunoassay testsett og en metode for påvisning av antistoffer fremkaltav HIV |
| ATE426035T1 (de) | 2001-05-03 | 2009-04-15 | Fit Biotech Oy | Neue expressionsvektoren und deren verwendungen |
| US7927580B2 (en) | 2004-03-16 | 2011-04-19 | Nanirx, Inc. | Tat-based immunomodulatory compositions and methods of their discovery and use |
| EP2411043B1 (en) * | 2009-03-23 | 2013-07-31 | PIN Pharma, Inc. | Treatment of cancer with immunostimulatory hiv tat derivative polypeptides |
| CN105705164A (zh) * | 2013-10-04 | 2016-06-22 | 品诺制药公司 | 用于癌症治疗的免疫刺激性hiv tat衍生多肽 |
-
2013
- 2013-12-06 RU RU2015126776A patent/RU2653754C2/ru active
- 2013-12-06 CA CA2894166A patent/CA2894166A1/en active Pending
- 2013-12-06 AU AU2013355039A patent/AU2013355039B2/en active Active
- 2013-12-06 EP EP13860686.8A patent/EP2928910B1/en active Active
- 2013-12-06 US US14/099,475 patent/US9878001B2/en active Active
- 2013-12-06 NZ NZ708836A patent/NZ708836A/en unknown
- 2013-12-06 JP JP2015545885A patent/JP6607784B2/ja not_active Expired - Fee Related
- 2013-12-06 CN CN201380072338.1A patent/CN104981479B/zh active Active
- 2013-12-06 ES ES13860686T patent/ES2748423T3/es active Active
- 2013-12-06 WO PCT/US2013/073658 patent/WO2014089480A1/en not_active Ceased
- 2013-12-06 DK DK13860686.8T patent/DK2928910T3/da active
-
2015
- 2015-06-07 IL IL239271A patent/IL239271B/en active IP Right Grant
- 2015-06-08 ZA ZA2015/04100A patent/ZA201504100B/en unknown
-
2017
- 2017-12-21 US US15/850,253 patent/US20180185441A1/en not_active Abandoned
-
2019
- 2019-04-03 JP JP2019071040A patent/JP2019163259A/ja active Pending
-
2020
- 2020-11-18 US US16/951,811 patent/US20210069290A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016508121A5 (https=) | ||
| RU2015126776A (ru) | Лечение воспалительных, аутоиммунных и нейродегенеративных нарушений иммуннодепрессивными полипетидами, являющимися производными тат | |
| NZ748983A (en) | Antibodies specific for hyperphosphorylated tau and methods of use thereof | |
| FI2970398T3 (fi) | Rsv f -prefuusioproteiineja ja niiden käyttö | |
| NZ602548A (en) | Oligomer-specific amyloid beta epitope and antibodies | |
| JP2015521039A5 (https=) | ||
| MX2015003852A (es) | Anticuerpos que reconocen alfa-sinucleina. | |
| JP2016519569A5 (https=) | ||
| BR112014003420A2 (pt) | hemifumarato de tenofovir alafenamida | |
| RU2011152816A (ru) | ПРИМЕНЕНИЕ АНТИТЕЛА ПРОТИВ Tau pS422 ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ГОЛОВНОГО МОЗГА | |
| BR112014007086A2 (pt) | proteínas de função dual para o tratamento de distúrbios metabólicos | |
| JP2013504318A5 (https=) | ||
| JP2019513752A5 (https=) | ||
| NZ599791A (en) | Therapeutic peptides | |
| JP2016525095A5 (ja) | 環状ポリペプチド | |
| JPWO2019156137A5 (https=) | ||
| JP2018509393A5 (https=) | ||
| EA201171087A1 (ru) | СПОСОБЫ ВВЕДЕНИЯ (4aR,10aR)-1-н-ПРОПИЛ-1,2,3,4,4a,5,10,10a-ОКТАГИДРОБЕНЗО[g]ХИНОЛИН-6,7-ДИОЛА И РОДСТВЕННЫХ СОЕДИНЕНИЙ ЧЕРЕЗ СЛИЗИСТУЮ ОБОЛОЧКУ ПОЛОСТИ РТА, СЛИЗИСТУЮ ОБОЛОЧКУ НОСА ИЛИ КОЖУ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ | |
| JP2006506942A5 (https=) | ||
| EA201391387A1 (ru) | Нейропротекторные пептиды | |
| WO2014021942A1 (en) | Methods for limiting development of neurodegeneration | |
| MX2011012677A (es) | Conjugados de albumina-peptido amiloide y usos de los mismos. | |
| NZ703514A (en) | Fviii peptides for immune tolerance induction and immunodiagnostics | |
| JP2009533355A5 (https=) | ||
| PL4205732T3 (pl) | Kompozycja kannabinoidowa i jej zastosowanie w przygotowaniu leku do leczenia chorób neurodegeneracyjnych takich jak choroba parkinsona i choroba alzheimera |